CD4 and pulmonary fibrosis: Birjandi et al. found that treatment by IL-2 complex, used to expand CD4+CD25highFoxP3+ cells in the lung, leads to immune deviation that is dominated by type 2 immune response within the lung, and associated with exacerbate lung fibrosis (97).